Cargando…

Inverse regulation of serum osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand levels in patients with leg lesional vascular calcification: An observational study

We hypothesized that circulating osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels could be associated with vascular calcification, which is predominant in diabetes. The study included 71 Korean participants (36 with diabetes and 35 without diabetes), w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Ae Ran, Park, Yoonkyung, Chang, Jeong Hwan, Lee, Sang Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417519/ https://www.ncbi.nlm.nih.gov/pubmed/30855435 http://dx.doi.org/10.1097/MD.0000000000014489

Ejemplares similares

Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
por: El Baz, Tarek Z., et al.
Publicado: (2017)

Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
por: Aoki, Atsushi, et al.
Publicado: (2013)

Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification
por: Jiao, Mengyu, et al.
Publicado: (2022)

The Role of Osteoprotegerin and Its Ligands in Vascular Function
por: Rochette, Luc, et al.
Publicado: (2019)

Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated with Carotid Plaque Stability
por: Davaine, Jean-Michel, et al.
Publicado: (2014)

Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort
por: Audo, Rachel, et al.
Publicado: (2015)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
por: Chen, Yen-Liang, et al.
Publicado: (2023)

Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients
por: Okasha, Kamal M., et al.
Publicado: (2022)

Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013)

Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients
por: Lee, Jung Eun, et al.
Publicado: (2013)

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
por: Park, Hye-Rim, et al.
Publicado: (2003)

Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis
por: Min, Hosung, et al.
Publicado: (2000)

Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway
por: Liu, Wei, et al.
Publicado: (2015)

The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts
por: Burgess, Teresa L., et al.
Publicado: (1999)

Osteoprotegerin Inhibits Aortic Valve Calcification and Preserves Valve Function in Hypercholesterolemic Mice
por: Weiss, Robert M., et al.
Publicado: (2013)

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand Inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2020)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Calcium and Osteoprotegerin Levels Predict the Progression of the Abdominal Aortic Calcifications After Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2013)

Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis
por: Ávila, Marcela, et al.
Publicado: (2022)

Inverse Regulation of Serum Osteoprotegerin and B-Type Natriuretic Peptide Concentrations by Free Fatty Acids Elevation in Young Healthy Humans
por: Dobrzycka, Marta, et al.
Publicado: (2022)

Histopathological characterization of intimal lesions and arterial wall calcification in the arteries of the leg of elderly cadavers
por: Vos, Annelotte, et al.
Publicado: (2020)

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
por: Labovsky, Vivian, et al.
Publicado: (2012)

Calciphylaxis: Temporal Artery Calcification Preceding Widespread Skin Lesions and Penile Necrosis
por: Shah, Manzoor A., et al.
Publicado: (2012)

Vascular calcification does not predict anastomotic leak or conduit necrosis following oesophagectomy
por: Jefferies, Benjamin J, et al.
Publicado: (2019)

Calcifications on the Entire Legs of a Systemic Lupus Erythematosus Patient
por: Youn, Seungki, et al.
Publicado: (2016)

Effect of Breastfeeding on Serum Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Full Term Neonates
por: Rafeey, Mandana, et al.
Publicado: (2013)

Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway
por: Zhou, Shaoqiong, et al.
Publicado: (2013)

Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions
por: Fu, Ying-Xiao, et al.
Publicado: (2013)

High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome
por: Dekker, Mirthe, et al.
Publicado: (2021)

Correlation between osteoprotegerin and coronary artery calcification in diabetic subjects: a systematic review of observational studies
por: Vazirian, Fatemeh, et al.
Publicado: (2023)

Diabetes confers in vitro calcific potential on serum which associates with in vivo vascular calcification
por: Patidar, Ashish, et al.
Publicado: (2017)

Serum osteoprotegerin levels are related to height loss: The Tromsø Study
por: Jørgensen, Lone, et al.
Publicado: (2011)

Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients
por: Nemeth, Zsofia K., et al.
Publicado: (2015)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

Correction: Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway
por: Zhou, Shaoqiong, et al.
Publicado: (2013)

Calcific Myonecrosis of the Leg: A Rare Entity
por: Angelini, Andrea, et al.
Publicado: (2019)

Serum DHEA and Testosterone Levels Associate Inversely With Coronary Artery Calcification in Elderly Men
por: Ohlsson, Claes, et al.
Publicado: (2023)

Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease
por: Silaghi, Ciprian N., et al.
Publicado: (2020)

Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review
por: Pluquet, Maxime, et al.
Publicado: (2022)

Zika Virus Induces Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL)-Mediated Apoptosis in Human Neural Progenitor Cells
por: Lee, Jae Kyung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_63lothacmpoumlj1q111o9ptam